Follow-up after curative resection of colorectal cancer: a meta-analysis
- PMID: 17874269
- DOI: 10.1007/s10350-007-9030-5
Follow-up after curative resection of colorectal cancer: a meta-analysis
Abstract
Purpose: This is a systematic review to evaluate the impact of various follow-up intensities and strategies on the outcome of patients after curative surgery for colorectal cancer.
Methods: All randomized trials up to January 2007, comparing different follow-up intensities and strategies, were retrieved. Meta-analysis was performed by using the Forest plot review.
Results: Eight randomized, clinical trials with 2,923 patients with colorectal cancer undergoing curative resection were reviewed. There was a significant reduction in overall mortality in patients having intensive follow-up (intensive vs. less intensive follow-up: 21.8 vs. 25.7 percent; P = 0.01). Regular surveillance with serum carcinoembryonic antigen (P = 0.0002) and colonoscopy (P = 0.04) demonstrated a significant impact on overall mortality. However, cancer-related mortality did not show any significant difference. There was no significant difference in all-site recurrence and in local or distant metastasis. Detection of isolated local and hepatic recurrences was similar. Intensive follow-up detected asymptomatic recurrence more frequently (18.9 vs. 6.3 percent; P < 0.00001) and 5.91 months earlier than less intensive follow-up protocol; these were demonstrated with all investigation strategies used. Intensive surveillance program detected recurrences that were significantly more amenable to surgical reresection (10.7 vs. 5.7 percent; P = 0.0002). The chance of curative reresection were significantly better with more intensive follow-up (24.3 vs. 9.9 percent; P = 0.0001), independent of the investigation strategies used.
Conclusions: Intensive follow-up after curative resection of colorectal cancer improved overall survival and reresection rate for recurrent disease. However, the cancer-related mortality was not improved and the survival benefit was not related to earlier detection and treatment of recurrent disease.
Similar articles
-
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.BMC Cancer. 2003 Oct 6;3:26. doi: 10.1186/1471-2407-3-26. BMC Cancer. 2003. PMID: 14529575 Free PMC article.
-
Follow-up strategies for patients treated for non-metastatic colorectal cancer.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002200. doi: 10.1002/14651858.CD002200.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2016 Nov 24;11:CD002200. doi: 10.1002/14651858.CD002200.pub3. PMID: 17253476 Updated.
-
Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.Ann Oncol. 2015 Apr;26(4):644-656. doi: 10.1093/annonc/mdu543. Epub 2014 Nov 19. Ann Oncol. 2015. PMID: 25411419
-
Follow-up strategies for patients treated for non-metastatic colorectal cancer.Cochrane Database Syst Rev. 2002;(1):CD002200. doi: 10.1002/14651858.CD002200. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002200. doi: 10.1002/14651858.CD002200.pub2. PMID: 11869629 Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Cited by
-
Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study.Ann Fam Med. 2016 May;14(3):215-20. doi: 10.1370/afm.1919. Ann Fam Med. 2016. PMID: 27184991 Free PMC article.
-
The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.Int J Clin Oncol. 2017 Feb;22(1):96-101. doi: 10.1007/s10147-016-1027-4. Epub 2016 Aug 8. Int J Clin Oncol. 2017. PMID: 27503134
-
The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.J Gastrointest Surg. 2020 Jan;24(1):115-122. doi: 10.1007/s11605-019-04328-4. Epub 2019 Jul 31. J Gastrointest Surg. 2020. PMID: 31367895
-
Personalised surveillance after treatment for high-risk cancer.Oncotarget. 2019 Jan 22;10(7):694-695. doi: 10.18632/oncotarget.26619. eCollection 2019 Jan 22. Oncotarget. 2019. PMID: 30774771 Free PMC article. No abstract available.
-
Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action.Front Oncol. 2021 Dec 7;11:731350. doi: 10.3389/fonc.2021.731350. eCollection 2021. Front Oncol. 2021. PMID: 34950576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical